Johanna P. Daily
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Johanna P. Daily has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Elizabeth A. Winzeler
Department of Pediatrics, University of California, San Diego, School of Medicine, La Jolla, CA, USA
2 shared publications O. Ndir
Department of Parasitology and Mycology, Dantec Hospital, Cheikh Anta Diop University, Dakar, Senegal
2 shared publicationsS. Mboup
Laboratory of Bacteriology and Virology, Dantec Hospital, Dakar, Senegal
2 shared publications- Ali A. Sultan
Department of Immunology and Infectious Diseases, Harvard School of Public Health, 665 Huntington Avenue, Boston, Massachusetts, 02115, USA
1 shared publication Ali Sultan
Department of Immunology and Infectious Disease, Harvard School of Public Health, Boston, Massachusetts
1 shared publication- Amanda K. Lukens
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health
1 shared publication
Latest Publications
- Open Access
- 27 August 2008
- Published by Springer Nature in Malaria Journal
- Vol. 7 (1) , 167
Reduced paediatric hospitalizations for malaria and febrile illness patterns following implementation of community-based malaria control programme in rural Rwanda
Malaria control is currently receiving significant international commitment. As part of this commitment, Rwanda has undertaken a two-pronged approach to combating malaria via mass distribution of long-lasting insecticidal-treated nets and distribution of antimalarial medications by community health workers. This study attempted to measure the impact of these interventions on paediatric hospitalizations for malaria and on laboratory markers of disease severity.
- 27 August 2008
- Published by Springer Nature in Malaria Journal
- Vol. 7 (1) , 167
Open AccessReduced paediatric hospitalizations for malaria and febrile illness patterns following implementation of community-based malaria control programme in rural Rwanda
Malaria control is currently receiving significant international commitment. As part of this commitment, Rwanda has undertaken a two-pronged approach to combating malaria via mass distribution of long-lasting insecticidal-treated nets and distribution of antimalarial medications by community health workers. This study attempted to measure the impact of these interventions on paediatric hospitalizations for malaria and on laboratory markers of disease severity.
- Open Access
- 15 July 2008
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 198 (2) , 157-158
Iron deficiency during pregnancy: blessing or curse?
Iron deficiency is the most common micronutrient deficiency and the most common cause of anemia among pregnant women worldwide [1]. Pregnancy may require as much as 1000 mg of elemental iron to meet the demands for maternal red blood cell expansion and fetal erythropoiesis and to account for blood lost at delivery [2]. As part of its standards for maternal and neonatal care, the World Health Organization recommends routine iron supplementation of 60 mg daily for pregnant women living in areas where malnutrition is prevalent [3]. The rationale underlying this policy is the observed association of anemia with adverse pregnancy outcomes. Specifically, anemia has been linked with low birth weight, preterm birth, decreased infant iron stores, and consequent impaired cognition and growth of the child [4–7]. For the mother, severe anemia may increase the risks of cardiac failure or death from peripartum hemorrhage [7, 8]. In a recent review of 40 trials involving >12,000 women, routine daily iron supplementation increased hemoglobin levels by ∼7.5 g/dL and was associated with a decreased risk for anemia at term (relative risk, 0.56; 95% confidence interval, 0.40–0.78) for the 4 highest-quality studies [9].
- 15 July 2008
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 198 (2) , 157-158
Open AccessIron deficiency during pregnancy: blessing or curse?
Iron deficiency is the most common micronutrient deficiency and the most common cause of anemia among pregnant women worldwide [1]. Pregnancy may require as much as 1000 mg of elemental iron to meet the demands for maternal red blood cell expansion and fetal erythropoiesis and to account for blood lost at delivery [2]. As part of its standards for maternal and neonatal care, the World Health Organization recommends routine iron supplementation of 60 mg daily for pregnant women living in areas where malnutrition is prevalent [3]. The rationale underlying this policy is the observed association of anemia with adverse pregnancy outcomes. Specifically, anemia has been linked with low birth weight, preterm birth, decreased infant iron stores, and consequent impaired cognition and growth of the child [4–7]. For the mother, severe anemia may increase the risks of cardiac failure or death from peripartum hemorrhage [7, 8]. In a recent review of 40 trials involving >12,000 women, routine daily iron supplementation increased hemoglobin levels by ∼7.5 g/dL and was associated with a decreased risk for anemia at term (relative risk, 0.56; 95% confidence interval, 0.40–0.78) for the 4 highest-quality studies [9].
- 31 August 2006
- Published by Elsevier in Acta Tropica
- Vol. 99 (1) , 106-111
Defining the origin of Plasmodium falciparum resistant dhfr isolates in Senegal
- 31 August 2006
- Published by Elsevier in Acta Tropica
- Vol. 99 (1) , 106-111
Defining the origin of Plasmodium falciparum resistant dhfr isolates in Senegal
- Open Access
- 1 April 2005
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 191 (7) , 1196-1203
In Vivo Transcriptome ofPlasmodium falciparumReveals Overexpression of Transcripts That Encode Surface Proteins
Infections with the human parasite Plasmodium falciparum continue to present a great challenge to global health. Fundamental questions regarding the
- 1 April 2005
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 191 (7) , 1196-1203
Open AccessIn Vivo Transcriptome ofPlasmodium falciparumReveals Overexpression of Transcripts That Encode Surface Proteins
Infections with the human parasite Plasmodium falciparum continue to present a great challenge to global health. Fundamental questions regarding the
- Open Access
- 1 January 2004
- Published by Springer Nature in Malaria Journal
- Vol. 3 (1) , 30
In vivo transcriptional profiling of Plasmodium falciparum
Both host and pathogen factors contribute to disease outcome in Plasmodium falciparum infection. The feasibility of studying the P. falciparum in vivo transcriptome to understand parasite transcriptional response while it resides in the human host is presented. A custom made oligonucleotide array with probes based on the P. falciparum 3D7 laboratory strain chromosome 2 sequence was used to detect in vivo P. falciparum transcripts. This study analyzed transcripts from total RNA derived from small blood samples of P. falciparum infected patients and compared the in vivo expression profile to the in vitro cultivated 3D7 strain transcriptome. The data demonstrated that in vivo transcription can be studied from a small blood sample, despite the abundance of human RNA. The in vivo transcriptome is similar to the 3D7 ring stage transcriptome, but there are significant differences in genes encoding a sexual stage antigen and surface proteins. Whole genome transcription analysis of P. falciparum can be carried out successfully and further studies in selected patient cohorts may provide insight into parasite in vivo biology and defense against host immunity.
- 1 January 2004
- Published by Springer Nature in Malaria Journal
- Vol. 3 (1) , 30
Open AccessIn vivo transcriptional profiling of Plasmodium falciparum
Both host and pathogen factors contribute to disease outcome in Plasmodium falciparum infection. The feasibility of studying the P. falciparum in vivo transcriptome to understand parasite transcriptional response while it resides in the human host is presented. A custom made oligonucleotide array with probes based on the P. falciparum 3D7 laboratory strain chromosome 2 sequence was used to detect in vivo P. falciparum transcripts. This study analyzed transcripts from total RNA derived from small blood samples of P. falciparum infected patients and compared the in vivo expression profile to the in vitro cultivated 3D7 strain transcriptome. The data demonstrated that in vivo transcription can be studied from a small blood sample, despite the abundance of human RNA. The in vivo transcriptome is similar to the 3D7 ring stage transcriptome, but there are significant differences in genes encoding a sexual stage antigen and surface proteins. Whole genome transcription analysis of P. falciparum can be carried out successfully and further studies in selected patient cohorts may provide insight into parasite in vivo biology and defense against host immunity.
- 1 April 2003
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 126 (5) , 401-405
Prevalence of Plasmodium falciparum pfcrt polymorphisms and in vitro chloroquine sensitivity in Senegal
Mutations in pfcrt K76T are associated with chloroquine resistance in Plasmodium falciparum. Previous studies of K76T mutations in Senegal reported the association of T76 with in vitro-resistant isolates, but this mutation was also prevalent in chloroquine-sensitive isolates. This suggests involvement of additional genetic loci in modulating chloroquine resistance. Additional pfcrt polymorphisms at codons A220S, Q271E, N326S and R371I have been found in chloroquine-resistant isolates. We wanted to test if sequential acquisition of mutations at these codons leads to in vitro chloroquine resistance. Stepwise accumulation of mutations was not detected, rather there was almost complete linkage between the pfcrt K76T mutation and polymorphisms in these codons. Therefore these additional polymorphisms do not enhance the correlation between pfcrt T76 and chloroquine resistance in Senegal. These data suggest that in vitro chloroquine resistance requires the genetic background of the pfcrt K76T mutation and additional mutations in genetic loci outside the pfcrt gene.
- 1 April 2003
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 126 (5) , 401-405
Prevalence of Plasmodium falciparum pfcrt polymorphisms and in vitro chloroquine sensitivity in Senegal
Mutations in pfcrt K76T are associated with chloroquine resistance in Plasmodium falciparum. Previous studies of K76T mutations in Senegal reported the association of T76 with in vitro-resistant isolates, but this mutation was also prevalent in chloroquine-sensitive isolates. This suggests involvement of additional genetic loci in modulating chloroquine resistance. Additional pfcrt polymorphisms at codons A220S, Q271E, N326S and R371I have been found in chloroquine-resistant isolates. We wanted to test if sequential acquisition of mutations at these codons leads to in vitro chloroquine resistance. Stepwise accumulation of mutations was not detected, rather there was almost complete linkage between the pfcrt K76T mutation and polymorphisms in these codons. Therefore these additional polymorphisms do not enhance the correlation between pfcrt T76 and chloroquine resistance in Senegal. These data suggest that in vitro chloroquine resistance requires the genetic background of the pfcrt K76T mutation and additional mutations in genetic loci outside the pfcrt gene.